Literature DB >> 9476559

Healing human myocardial infarction associated with increased chymase immunoreactivity.

M J Daemen1, H Urata.   

Abstract

We studied the immunoreactivity of the chymase protein in normal human myocardium and in human myocardial infarctions at various postinfarction times using immuno-histochemistry. In noninfarcted hearts chymase was mainly present in cardiomyocytes and endothelial cells. At 6 h after infarction the ischemic cardiomyocytes had lost their chymase immunoreactivity. A portion of the smooth muscle alpha-actin-expressing myofibroblasts and some of the CD-68-positive macrophages, which both appear 4-6 days after infarction, contained chymase. Chymase was also found in mast cells, which were present in the normal myocardium and the healing scar. These data show that chymase, a protein that mediates the conversion of angiotensin I to angiotensin II via a non-angiotensin-converting-enzyme-dependent pathway is present in the normal adult human myocardium and is upregulated in the healing tissue after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476559

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  2 in total

1.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

2.  Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction.

Authors:  Martin Houde; Adel Schwertani; Hanène Touil; Louisane Desbiens; Otman Sarrhini; Roger Lecomte; Martin Lepage; Hugo Gagnon; Shinji Takai; Gunnar Pejler; Danielle Jacques; Fernand Gobeil; Robert Day; Pedro D'Orléans-Juste
Journal:  Front Pharmacol       Date:  2018-08-31       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.